Vale SA
VALE
Microsoft
MSFT
D.R. Horton
DHI
4
Toll Brothers
TOL
5
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
LLY Eli Lilly and Co
- 720.910
- -32.800-4.35%
Close Apr 10 16:00 ET
- 727.120
- +6.210+0.86%
Pre 07:56 ET
683.41BMarket Cap61.56P/E (TTM)
741.950High691.765Low4.18MVolume738.900Open753.710Pre Close3.00BTurnover0.44%Turnover Ratio61.56P/E (Static)947.99MShares969.23352wk High48.15P/B681.81BFloat Cap677.09152wk Low5.20Dividend TTM945.76MShs Float969.233Historical High0.72%Div YieldTTM6.66%Amplitude5.269Historical Low717.057Avg Price1Lot Size
About Eli Lilly and Co Company
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Company Profile
SymbolLLY
Company NameEli Lilly and Co
Listing DateApr 1, 1973
Founded1876
CEOMr. David A. Ricks
MarketNYSE
Employees47000
Fiscal Year Ends12-31
AddressLilly Corporate Center
CityIndianapolis
ProvinceIndiana
CountryUnited States of America
Zip Code46285
Phone1-317-276-2000
Websitehttp://www.lilly.com
Company Executives
- Name
- Position
- Salary
- David A. Ricks
- Chairman of the Board, President and Chief Executive Officer
- 29.24M
- Lucas Montarce
- Executive Vice President and Chief Financial Officer
- 2.95M
- Eric Dozier
- Executive Vice President and Chief People Officer
- --
- Donald A. Zakrowski
- Senior Vice President, Finance and Chief Accounting Officer
- --
- Diogo Rau
- Executive Vice President, Chief Information Officer and Chief Digital Officer
- --
- Dr. Daniel M. Skovronsky, M.D.,PhD
- Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology
- 12.64M
- Melissa Seymour
- Executive Vice President, Global Quality
- --
- Anne E. White
- Executive Vice President and President, Lilly Neuroscience
- --
- Anat Hakim
- Executive Vice President, General Counsel and Secretary
- 7.48M
- Patrik Jonsson
- Executive Vice President and President, Lilly Cardiometabolic Health; President, Lilly USA
- --
- Jacob S. Van Naarden
- Executive Vice President and President, Lilly Oncology
- 5.77M
- Ilya Yuffa
- Executive Vice President; President, Lilly International
- --
- Edgardo Hernandez
- Executive Vice President and President, Manufacturing Operations
- --
- Kimberly H. Johnson
- Independent Director
- 336.00K
- Gabrielle Sulzberger, J.D.,M.B.A.
- Independent Director
- 366.75K
- Ralph Alvarez
- Independent Director
- 361.00K
- Juan R. Luciano
- Lead Independent Director
- 398.00K
- Jon R. Moeller
- Independent Director
- 9.92K
- Jon Erik Fyrwald
- Independent Director
- 386.55K
- Jamere Jackson
- Independent Director
- 365.00K
- Dr. William G. Kaelin, Jr,M.D.
- Independent Director
- 400.15K
- Dr. Mary Lynne Hedley,PhD
- Independent Director
- 339.00K
- Dr. Katherine Baicker, PhD
- Independent Director
- 361.00K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025